Varian Medical Systems, Inc. (VAR)’s EVP and Pres. Oncology Sys. Kolleen Kennedy Unloaded 1,087 Shares of the Company, Equus Total Return Has 1.33 Sentiment

June 14, 2017 - By Henry Gaston

Equus Total Return, Inc. is a closed-end management investment company. The company has market cap of $30.69 million. The Company’s investment objective is to maximize the total return to its stockholders in the form of current investment income and long-term capital gains by investing in the debt and equity securities of small and middle market capitalization companies that are generally not publicly traded at the time of its investment. It has a 8.55 P/E ratio. It also seeks to purchase interests in gas and oil properties.

Mr. Kolleen Kennedy, the crucial EVP and Pres. Oncology Sys. at Varian Medical Systems Inc has not a long ago been linked with an open market transaction of 1,087 shares of the corporation, valued at $101.2 per share. The total stocks unloaded with a value of of $110,000 US Dollars. Kolleen is trying to quietly decrease her company’s share, same as she did in the last month. She unloaded another 56,573 shares worth $5,643,900 USD. Kolleen Kennedy owns roughly 0.03% of Varian Medical Systems Inc’s total market cap or 26,600 shares. Considering the size of the deal, it is difficult to stay ignored.

The stock increased 0.44% or $0.01 on June 13, reaching $2.3. About shares traded. Equus Total Return, Inc. (EQS) has risen 61.81% since June 14, 2016 and is uptrending. It has outperformed by 45.11% the S&P500.

Bulldog Investors Llc holds 0.26% of its portfolio in Equus Total Return, Inc. for 497,162 shares. Kazazian Asset Management Llc owns 32,573 shares or 0.09% of their US portfolio. Moreover, Thomas J. Herzfeld Advisors Inc. has 0.06% invested in the company for 61,909 shares. The New Jersey-based Landscape Capital Management L.L.C. has invested 0.05% in the stock. Blue Bell Private Wealth Management Llc, a Pennsylvania-based fund reported 35,584 shares.

Since January 1, 0001, it had 5 buys, and 0 sales for $1.94 million activity.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has market cap of $9.36 billion. The Firm also has Varian Particle Therapy and the activities of the Ginzton Technology Center (GTC). It has a 32.2 P/E ratio. The Company’s VPT business develops, designs, makes, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer.

Investors sentiment increased to 0.9 in 2016 Q4. Its up 0.01, from 0.89 in 2016Q3. It improved, as 38 investors sold Varian Medical Systems, Inc. shares while 188 reduced holdings. 59 funds opened positions while 144 raised stakes. 88.84 million shares or 2.22% less from 90.86 million shares in 2016Q3 were reported. Ngam Ltd Partnership owns 396,139 shares. Kcg Hldg Incorporated holds 0.05% or 21,017 shares in its portfolio. 33,580 are owned by Papp L Roy Associates. Hexavest has 2,023 shares. Dekabank Deutsche Girozentrale stated it has 86,250 shares or 0.08% of all its holdings. Klingenstein Fields And Co Limited Co invested in 0.05% or 11,500 shares. Exxonmobil Investment Mngmt Tx reported 21,621 shares. Cadence Cap Mngmt Limited Liability Corporation holds 2,400 shares. Commerce Bancorp holds 0.01% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR) for 4,999 shares. Mackenzie Financial holds 0.25% or 461,647 shares in its portfolio. Asset Mngmt One Ltd has 204,243 shares. Security invested in 0.26% or 8,000 shares. Wellington Mngmt Group Inc Llp reported 0.04% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Tiemann Advsr Limited Com stated it has 0.67% in Varian Medical Systems, Inc. (NYSE:VAR). 136,791 are owned by Jpmorgan Chase And Communication.

Among 10 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Varian Medical Systems Inc. has $99 highest and $75 lowest target. $90.14’s average target is -11.64% below currents $102.01 stock price. Varian Medical Systems Inc. had 18 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Buy” rating by Brean Capital on Thursday, April 28. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Sector Perform” rating by RBC Capital Markets on Monday, January 23. Robert W. Baird maintained the shares of VAR in report on Wednesday, September 28 with “Neutral” rating. The firm earned “Neutral” rating on Thursday, November 12 by Citigroup. The company was downgraded on Thursday, January 26 by Evercore. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Outperform” rating given on Tuesday, January 12 by Barrington Research. Goldman Sachs downgraded Varian Medical Systems, Inc. (NYSE:VAR) on Monday, September 28 to “Sell” rating. The firm earned “Sector Perform” rating on Tuesday, December 22 by RBC Capital Markets. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Sector Perform” rating by RBC Capital Markets on Thursday, April 27. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Buy” rating given on Monday, May 8 by Citigroup.

Since January 5, 2017, it had 0 buys, and 12 sales for $13.62 million activity. On Wednesday, May 31 KUO JOHN W sold $1.98 million worth of Varian Medical Systems, Inc. (NYSE:VAR) or 19,819 shares. Shares for $147,761 were sold by LARET MARK R on Thursday, June 8. Another trade for 56,573 shares valued at $5.64M was made by KENNEDY KOLLEEN T on Thursday, June 1. Another trade for 13,334 shares valued at $1.18 million was made by WILSON DOW R on Thursday, January 5. On Tuesday, May 2 BOSTROM SUSAN L sold $326,902 worth of Varian Medical Systems, Inc. (NYSE:VAR) or 3,589 shares. Shares for $1.65M were sold by GUERTIN TIMOTHY E.

The stock decreased 0.04% or $0.04 during the last trading session, reaching $102.01. About shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since June 14, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.